The Inamed? Silicone-Filled Breast Implant is a silicone shell filled with silicone gel. The implants are available with textured and smooth surfaces and with various profiles and sizes.
The U. S. Food and Drug Administration (FDA) today expanded the approved use of Herceptin, a biological cancer drug. The new indication is for Herceptin, in combination with other cancer drugs, for the treatment of HER2 positive breast cancer after surgery (lumpectomy or mastectomy). FDA granted priority review to the supplemental application for Herceptin.
After rigorous scientific review, the U.S. Food and Drug Administration (FDA) today approved the marketing of silicone gel-filled breast implants made by two companies for breast reconstruction in women of all ages and breast augmentation in women ages 22 and older. The products are manufactured by Allergan Corp. (formerly Inamed Corp.), Irvine, Calif., and Mentor Corp., Santa Barbara, Calif.
Following two studies of patients who were treated with cardiac stents, physicians at Rhode Island Hospital continue to recommend drug-eluting stents (DES) as a safe and effective treatment.
A new study showed that it can be safe and cost-efficient to discharge pediatric tonsillectomy patients after a short post-operative recovery period at an outpatient surgery center.
A new method of treating mitral regurgitation (MR), the leaking of blood through the mitral valve into the heart chamber, provides a less-invasive alternative to open heart surgery. A study published in Journal of Interventional Cardiology found that a variety of advances have allowed for the potential treatment of MR through various catheter techniques, similar to angioplasty. While over 50,000 mitral valve surgical procedures are performed annually, open surgery is an undesirable option, especially for high-risk patients.
A pilot project launched today alongside the booklet Choosing your hospital, offers members of the public access to healthcare provider information from their local library and GP surgery.
Royal Philips (NYSE: PHG, AEX: PHI) today unveiled a range of new cardiovascular solutions that supply cardiologists with insightful clinical knowledge for more confident diagnoses at the 2006 American Heart Association (AHA) Scientific Sessions meeting. At AHA, Philips revealed the industry?s smallest transducer for 4D cardiac ultrasound imaging in infants and children to help cardiologists accurately view a patient?s cardiac structure and blood flow by improving access to the heart.
It is being reported in the Journal Nature, that stem cell injections given to dogs may hold clues to treating people with muscular dystrophy.
A dioxin toxin contained in the herbicide Agent Orange affects male reproductive health by limiting the growth of the prostate gland and lowering testosterone levels, researchers at UT Southwestern Medical Center have found in a cohort study of more than 2,000 Air Force veterans who served during the Vietnam War.